Neuren is also investigating the effects of NNZ-2591 in models of other neurodevelopmental disorders, with a view to initiating clinical trials in more than one indication.
So PhMS and...? Could Multiple Sclerosis be described as neurodevelopmental? I'm thinking no...
Anyway, another news point at some stage: the plus one.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$13.02 |
Change
0.060(0.46%) |
Mkt cap ! $1.612B | |||
| Open | High | Low | Value | Volume |
| $12.82 | $13.02 | $12.70 | $716.7K | 55.87K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 144 | $13.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.02 | 18 | 2 |
View Market Depth
| Last trade - 10.29am 17/06/2025 (20 minute delay) ? |
| NEU (ASX) Chart |